LEPTOSPIRA SP - ANVISA Registration 81325990397
Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81325990397 and manufactured by HANGZHOU ALLTEST BIOTECH CO. LTD. The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Jul 28, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including INSTITUT VIRION\SERION GMBH, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81325990397
25351462579202427
19933144000129
Company Information
Dates and Status
Jul 28, 2025
28/07/2035
09/18/2025 19:00:01
LEPTOSPIRA SP
LEPTOSPIRA ELISA IgM
VIRCELL S.L.
10259610257
Jun 09, 2025
LEPTOSPIRA SP
LEPTOSPIRA ELISA IgM
Not specified
10259610257
Jun 09, 2025
LEPTOSPIRA SP
LEPTOSPIROSE IgG/IgM RAPID TEST
HANGZHOU ALLTEST BIOTECH CO. LTD
80638720241
Sep 23, 2024
LEPTOSPIRA SP
LEPTOSPIROSE IgG/IgM RAPID TEST
Not specified
80638720241
Sep 23, 2024
LEPTOSPIRA SP
LEPTOSPIRA VIRCLIA® IgM MONOTEST
VIRCELL S.L.
81816720070
Sep 23, 2024

